Search research articles
Contact Us
Filters
Showing results (181-190 of 617) with videos related to
Page
of 62
Sort By:
Analytical Chemistry
|
December 21, 2019
Implementing In-Cell Fast Photochemical Oxidation of Proteins in a Platform Incubator with a Movable XY Stage
Danté T Johnson, Benjamin Punshon-Smith, Jessica A Espino, et al.
European Journal of Gynaecological Oncology
|
August 19, 2000
Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancer
M L Donato, R E Champlin, J T Wharton, et al.
Gynecologic Oncology
|
May 28, 2013
Low-grade serous carcinoma: new concepts and emerging therapies
Ignacio Romero, Charlotte C Sun, Kwong K Wong, et al.
Gynecologic Oncology
|
September 19, 1998
A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix
M Morris, K R Brader, T W Burke, et al.
Obstetrics and Gynecology
|
October 1, 1981
Single-agent cis-platinum therapy for advanced ovarian cancer
D M Gershenson, J T Wharton, J Herson, et al.
Gynecologic Oncology
|
March 1, 1997
Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapy
M A Dimopoulos, D Daliani, W Pugh, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 1991
Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma
P J Eifel, D M Gershenson, L Delclos, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
September 28, 2002
Peritoneal lesions in guinea pigs treated with hormones
Elvio G Silva, Jennifer L Ross, David M Gershenson, et al.
Obstetrics and Gynecology
|
January 5, 2002
Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential
Marta A Crispens, Diane Bodurka, Michael Deavers, et al.
Gynecologic Oncology
|
May 1, 1986
A phase II trial of 4-demethoxydaunorubicin in refractory epithelial ovarian cancer
J J Kavanagh, L J Copeland, D M Gershenson, et al.
Page
of 62
Search research articles
Search
Showing results (181-190 of 617) with videos related to
Sort By:
Page
of 62
Analytical Chemistry
|
December 21, 2019
Implementing In-Cell Fast Photochemical Oxidation of Proteins in a Platform Incubator with a Movable XY Stage
Danté T Johnson, Benjamin Punshon-Smith, Jessica A Espino, et al.
European Journal of Gynaecological Oncology
|
August 19, 2000
Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancer
M L Donato, R E Champlin, J T Wharton, et al.
Gynecologic Oncology
|
May 28, 2013
Low-grade serous carcinoma: new concepts and emerging therapies
Ignacio Romero, Charlotte C Sun, Kwong K Wong, et al.
Gynecologic Oncology
|
September 19, 1998
A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix
M Morris, K R Brader, T W Burke, et al.
Obstetrics and Gynecology
|
October 1, 1981
Single-agent cis-platinum therapy for advanced ovarian cancer
D M Gershenson, J T Wharton, J Herson, et al.
Gynecologic Oncology
|
March 1, 1997
Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapy
M A Dimopoulos, D Daliani, W Pugh, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 1991
Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma
P J Eifel, D M Gershenson, L Delclos, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
September 28, 2002
Peritoneal lesions in guinea pigs treated with hormones
Elvio G Silva, Jennifer L Ross, David M Gershenson, et al.
Obstetrics and Gynecology
|
January 5, 2002
Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential
Marta A Crispens, Diane Bodurka, Michael Deavers, et al.
Gynecologic Oncology
|
May 1, 1986
A phase II trial of 4-demethoxydaunorubicin in refractory epithelial ovarian cancer
J J Kavanagh, L J Copeland, D M Gershenson, et al.
Page
of 62